NGM Biopharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACHL
|
Achilles Therapeutics plc | $0.72 | $37.06 M | -0.56 | 204 | $0 |
 ASMB
|
Assembly Biosciences, Inc. | $18.01 | $78.73 M | -1.35 | 65 | $7.16 M |
 CCCC
|
C4 Therapeutics, Inc. | $6.43 | $320.64 M | -1.97 | 145 | $20.76 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 ERAS
|
Erasca, Inc. | $2.97 | $647.94 M | -2.83 | 126 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $9.72 | $332.53 M | -2.73 | 116 | $34.16 M |
 GBIO
|
Generation Bio Co. | $2.58 | $216.88 M | -1.28 | 174 | $5.90 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $6.08 | $243.38 M | -1.59 | 129 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.59 | $244.54 M | -1.32 | 152 | $2.24 M |
 KROS
|
Keros Therapeutics, Inc. | $56.98 | $1.76 B | -9.45 | 149 | $151,000 |
 KZR
|
Kezar Life Sciences, Inc. | $0.57 | $49.85 M | -0.49 | 58 | $7.00 M |
 LYEL
|
Lyell Immunopharma, Inc. | $1.23 | $619.50 M | -2.7 | 224 | $130,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.75 | $652.38 M | -6.03 | 28 | $0 |
 NKTX
|
Nkarta, Inc. | $5.71 | $465.09 M | -2.81 | 150 | $0 |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 NXTC
|
NextCure, Inc. | $1.40 | $38.88 M | -0.61 | 82 | $0 |
 PRLD
|
Prelude Therapeutics Incorporated | $2.78 | $205.99 M | -2.02 | 128 | $0 |
 RZLT
|
Rezolute, Inc. | $5.25 | $229.57 M | -5.02 | 41 | $0 |
 SANA
|
Sana Biotechnology, Inc. | $4.47 | $1.55 B | -4.59 | 328 | $0 |
 TIL
|
Instil Bio, Inc. | $84.75 | $69.59 M | -0.56 | 49 | $0 |